GANX   $2.3  -5.35% Market Closed

Gain Therapeutics Inc
Total Cash 16.94M
totalCashPerShare 0.663
EBITDA -21.82M
Total Debt 807.57K
quickRatio 2.644
currentRatio 2.842
Total Revenue 0.00
debtToEquity 6.853
Revenue/Share 0.0
ROA -0.72955
ROE -1.8882699
grossProfits
freeCashflow -10.06M
operatingCashflow -18.97M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 41.84M
forwardPE -2.550562
floatShares 24.23M
sharesOutstanding 25.54M
sharesShort 572.01K
sharesShortPriorMonth 580.28K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.12%
Short Ratio help_outline 1.60%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.468
Price To Book help_outline 4.85
earningsQuarterlyGrowth
netIncomeToCommon -21.60M
trailingEps -1.34%
forwardEps -0.89%
enterpriseToEbitda -1.92
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.21 3Q 2024
institutionsCount 31
lastUpdated Nov. 7, 2024, 4:58 a.m.